Healthcare and laboratory label demand in Western Europe is anticipated to exhibit a CAGR of 3.80% from 2024 to 2034. Healthcare and laboratory labels in Western Europe are poised to witness significant opportunities, with US$ 1,959.80 million in 2024.
The presence of numerous players in the healthcare and laboratory label industry drives innovation and competitive pricing, leading to advancements in label technologies and materials in Western Europe to capture share. By 2034, healthcare and laboratory label adoption in Western Europe will likely secure US$ 2,845.20 million.
Key Insights and Highlights to Understand Emerging and Fast-growing Opportunities
| Attributes | Details |
|---|---|
| Expected Value in 2024 | US$ 1,959.80 million |
| Projected Value in 2034 | US$ 2,845.20 million |
| CAGR Estimation from 2024 to 2034 | 3.80% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
This section brings to the fore key dynamics shaping healthcare and laboratory label demand in Western Europe. Integration of labeling systems with digital health platforms, electronic medical records, and laboratory information management systems is on the rise in Western Europe.
The adoption of advanced labeling technologies, such as RFID, smart labels, and barcode systems, enhances supply chain management, reduces errors, and improves overall efficiency in healthcare and laboratory settings in Japan. Consequently, the healthcare and laboratory label ecosystem in Japan is poised to rise.
The healthcare and laboratory label landscape in Korea is gaining traction amid the increasing need for incorporating tamper-proof packaging solutions. Healthcare providers are seeking to deploy anti-counterfeiting technologies to prevent any theft or duplication of healthcare equipment, thus spurring demand.
Deployment of Healthcare and Laboratory Label in Western Europe:
| Attributes | Deployment of Healthcare and Laboratory Label in Western Europe |
|---|---|
| CAGR from 2024 to 2034 | 3.80% |
| Valuation in 2024 | US$ 1,959.80 million |
| Key Trend |
|
| Key Challenge |
|
Uptake of Healthcare and Laboratory Labels in Japan:
| Attributes | Uptake of Healthcare and Laboratory Labels in Japan |
|---|---|
| CAGR from 2024 to 2034 | 4.20% |
| Valuation in 2024 | US$ 482.9 million |
| Key Trend |
|
| Key Challenge |
|
Healthcare and laboratory Label in Korea:
| Attributes | Healthcare and laboratory Label in Korea |
|---|---|
| CAGR from 2024 to 2034 | 5.10% |
| Valuation in 2024 | US$ 305.6 million |
| Key Trend |
|
| Key Challenge |
|
Principal Consultant
Innovations in labeling technologies, such as smart labels, RFID, and barcode systems, are being adopted to enhance traceability, inventory management, and accuracy in healthcare and laboratory settings. The healthcare and laboratory labels in the United Kingdom is expected to grow with a CAGR of 3.90% from 2024 to 2034.
Continuous investment in healthcare, including pharmaceuticals, medical devices, and laboratory equipment, contributes to sustained demand for accurate and compliant labeling solutions.
Germany is a prominent market for medical devices, necessitating healthcare and laboratory labeling solutions compliant with the EU Medical Devices Regulation (MDR) for devices used in various healthcare settings. The healthcare and laboratory label in Germany is expected to grow with a CAGR of 3.40% from 2024-2034.
country's emphasis on research and development fuels demand for labeling solutions in laboratory settings, including specimen identification, diagnostic tools, and equipment labeling. Integration of labeling systems with digital health platforms, electronic medical records, and laboratory information management systems is gaining traction, influencing labeling trends in Germany.
Plastic remains the prominent material in the healthcare and laboratory label in Western Europe with a share of 63.10%. Plastic labels offer durability and resilience, capable of withstanding various environmental conditions such as moisture, chemicals, and sterilization processes. This durability is crucial in healthcare settings where labels may encounter harsh conditions.
Plastic labels often come with strong adhesive properties, ensuring they remain firmly attached to surfaces, which is essential for critical information to remain intact and readable over time. Plastic labels provide excellent print quality and clarity, ensuring the information on the label remains legible even after prolonged use or exposure to different conditions.
| Attribute | Details |
|---|---|
| Material | Plastics |
| Value Share | 63.10% |
Based on end-use, the pharmaceutical segment is likely to be a prominent utilizer of healthcare and laboratory labels. A revenue share of 29.70% is expected for the segment in 2024.
The pharmaceutical industry operates under stringent regulations regarding labeling and packaging. Compliance with regulations like the EU Medical Device Regulation (MDR), In Vitro Diagnostic Regulation (IVDR), and pharmaceutical standards necessitates highly specialized and compliant labeling, driving significant demand from this sector.
Pharmaceuticals encompass a wide range of products, including prescription drugs, over-the-counter medicines, vaccines, and biologics, each requiring specific labeling to comply with regulations and address the complexities of these products. The continuous increase in healthcare spending, especially on pharmaceuticals, drives the demand for accurate, informative, and compliant labeling solutions.
| Attribute | Details |
|---|---|
| End Use | Pharmaceutical |
| Value Share | 29.70% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Industry players in healthcare and laboratory labels in Western Europe are using mergers & acquisitions as a critical strategy for expanding their geographical presence and for more business in terms of revenue.
Companies often collaborate with healthcare providers, pharmaceutical companies, or technology firms to develop innovative labeling solutions.
Product Offering
| Attribute | Details |
|---|---|
| Estimated Industry Size in 2024 | US$ 1,959.80 million |
| Projected Industry Size in 2034 | US$ 2845.20 million |
| Anticipated CAGR between 2024 to 2034 | 3.80% CAGR |
| Historical Analysis of Demand for Healthcare and laboratory Label in Western Europe | 2019 to 2023 |
| Demand Forecast for Healthcare and laboratory Label in Western Europe | 2024 to 2034 |
| Report Coverage | Industry Size, Industry Trends, Analysis of key factors influencing Healthcare and laboratory Label in Western Europe, Insights on Global Players and their Industry Strategy in Western Europe, Ecosystem Analysis of Local Providers in Western Europe |
| Key Country Analyzed while Studying Opportunities Healthcare and laboratory Label in Western Europe | The United Kingdom, Germany, Italy, France, Spain, Rest of Western Europe |
| Key Companies Profiled | Diagramm Halbach GmbH & Co KG; UPM Raflatac Corporation; Advanced Labelling Systems Ltd.; Avery Dennison Corporation; CCL Industries Inc.; 3M Company; Multi-Color Corporation; Brady Corporation; Sato Holdings Corporation; Weber Packaging Solutions Inc.; Schreiner Group GmbH & Co. |
The estimated valuation of the healthcare and laboratory label industry in Western Europe is US$ 1,959.80 million in 2024.
The anticipated CAGR for the healthcare and laboratory label ecosystem through 2034 is 3.80%.
Demand for healthcare and laboratory label in Western Europe will be US$ 2845.20 million by 2034.
Plastics remain the top segment in healthcare and laboratory label industry in Western Europe.
1. Executive Summary 1.1. Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Industry Analysis and Outlook 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By Material 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2024 to 2034 5.3.1. Nylon 5.3.2. Polyester 5.3.3. Polyolefin 5.3.4. Vinyl 5.3.5. Paper 5.3.6. Others 5.4. Y-o-Y Growth Trend Analysis By Material, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Material, 2024 to 2034 6. Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By End-user 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-user, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-user, 2024 to 2034 6.3.1. Pharmaceuticals 6.3.2. Nutraceuticals 6.3.3. Medical Devices 6.3.4. Blood Banks 6.3.5. Hospital Services 6.3.6. Laboratories 6.4. Y-o-Y Growth Trend Analysis By End-user, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By End-user, 2024 to 2034 7. Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By Country 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Country, 2019 to 2023 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Country, 2024 to 2034 7.3.1. UK 7.3.2. Germany 7.3.3. Italy 7.3.4. France 7.3.5. Spain 7.3.6. Rest of Western Europe 7.4. Market Attractiveness Analysis By Country 8. UK Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 8.2.1. By Region 8.2.1.1. England 8.2.1.2. Scotland 8.2.1.3. Wales 8.2.1.4. Northern Ireland 8.2.2. By Material 8.2.3. By End-user 8.3. Market Attractiveness Analysis 8.3.1. By Region 8.3.2. By Material 8.3.3. By End-user 8.4. Key Takeaways 9. Germany Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Region 9.2.1.1. North-east (Germany) 9.2.1.2. North-west (Germany) 9.2.1.3. Central (Germany) 9.2.1.4. South (Germany) 9.2.1.5. Other(Germany) 9.2.2. By Material 9.2.3. By End-user 9.3. Market Attractiveness Analysis 9.3.1. By Region 9.3.2. By Material 9.3.3. By End-user 9.4. Key Takeaways 10. Italy Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Region 10.2.1.1. North (Italy) 10.2.1.2. Central (Italy) 10.2.1.3. South (Italy) 10.2.1.4. Islands (Italy) 10.2.2. By Material 10.2.3. By End-user 10.3. Market Attractiveness Analysis 10.3.1. By Region 10.3.2. By Material 10.3.3. By End-user 10.4. Key Takeaways 11. France Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By Region 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Region 11.2.1.1. Northern (France) 11.2.1.2. Central (France) 11.2.1.3. Southern (France) 11.2.1.4. Eastern (France) 11.2.2. By Material 11.2.3. By End-user 11.3. Market Attractiveness Analysis 11.3.1. By Region 11.3.2. By Material 11.3.3. By End-user 11.4. Key Takeaways 12. Spain Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034, By Region 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Region 12.2.1.1. Basque Country 12.2.1.2. Andalusia 12.2.1.3. Extremadura 12.2.1.4. Catalonia 12.2.1.5. Valencia 12.2.1.6. Rest of Spain 12.2.2. By Material 12.2.3. By End-user 12.3. Market Attractiveness Analysis 12.3.1. By Region 12.3.2. By Material 12.3.3. By End-user 12.4. Key Takeaways 13. Rest of Industry Analysis and Outlook 2019 to 2023 and Forecast 2024 to 2034 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Material 13.2.2. By End-user 13.3. Market Attractiveness Analysis 13.3.1. By Material 13.3.2. By End-user 13.4. Key Takeaways 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Material 14.3.3. By End-user 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Diagramm Halbach GmbH & Co KG 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.1.5.2. Product Strategy 15.1.1.5.3. Channel Strategy 15.1.2. UPM Raflatac Corporation 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.2.5.2. Product Strategy 15.1.2.5.3. Channel Strategy 15.1.3. Advanced Labelling Systems, Ltd. 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.3.5.2. Product Strategy 15.1.3.5.3. Channel Strategy 15.1.4. Avery Dennison Corporation 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.4.5.2. Product Strategy 15.1.4.5.3. Channel Strategy 15.1.5. CCL Industries Inc. 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.5.5.2. Product Strategy 15.1.5.5.3. Channel Strategy 15.1.6. 3M Company 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.6.5.2. Product Strategy 15.1.6.5.3. Channel Strategy 15.1.7. Multi-Color Corporation 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.7.5.2. Product Strategy 15.1.7.5.3. Channel Strategy 15.1.8. Brady Corporation 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.8.5.2. Product Strategy 15.1.8.5.3. Channel Strategy 15.1.9. Sato Holdings Corporation 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.9.5.2. Product Strategy 15.1.9.5.3. Channel Strategy 15.1.10. Weber Packaging Solutions, Inc. 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.10.5.2. Product Strategy 15.1.10.5.3. Channel Strategy 15.1.11. Schreiner Group GmbH & Co. 15.1.11.1. Overview 15.1.11.2. Product Portfolio 15.1.11.3. Profitability by Market Segments 15.1.11.4. Sales Footprint 15.1.11.5. Strategy Overview 15.1.11.5.1. Marketing Strategy 15.1.11.5.2. Product Strategy 15.1.11.5.3. Channel Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Packaging Insights
View Reports
Healthcare and Laboratory Label Industry Analysis in Western Europe
